Belmont Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,366
Closed -$424K 179
2024
Q2
$424K Hold
4,366
0.08% 82
2024
Q1
$393K Hold
4,366
0.11% 64
2023
Q4
$348K Hold
4,366
0.15% 58
2023
Q3
$310K Hold
4,366
0.17% 53
2023
Q2
$336K Hold
4,366
0.19% 41
2023
Q1
$328K Hold
4,366
0.27% 27
2022
Q4
$344K Hold
4,366
0.37% 25
2022
Q3
$307K Buy
+4,366
New +$342K 0.36% 22

Other funds holding CL

Belmont Capital's CL Position: Q3 2024 in Review

Belmont Capital sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 4,366 shares — an estimated $424K sold.

Belmont Capital first reported a position in CL in Q3 2022 and held it in 8 quarters. The position peaked at $424K in Q2 2024. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Belmont Capital reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
  • Belmont Capital sold 4,366 Colgate-Palmolive shares in Q3 2024, an estimated $424K.
  • Belmont Capital first reported a position in Colgate-Palmolive in Q3 2022 and held it in 8 quarters.
  • Belmont Capital's Colgate-Palmolive position peaked at $424K in Q2 2024.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Belmont Capital's 13F filing for Q3 2024, filed 7 Nov 2024.